Ketorolac IM Dosing Frequency
Administer ketorolac IM every 6 hours, with a maximum treatment duration of 5 days. 1
Standard Dosing Regimen
For patients under 65 years of age:
- 30 mg IM every 6 hours 1
- Maximum daily dose: 120 mg 2, 1
- Treatment duration: Not to exceed 5 days 2, 1
For patients 65 years and older, renally impaired, or weighing less than 50 kg:
Administration Technique
- Inject slowly and deeply into the muscle 1
- The analgesic effect begins in approximately 30 minutes with maximum effect at 1-2 hours 1
- Duration of analgesic effect is typically 4-6 hours 1
Critical Safety Considerations
Before administering ketorolac:
- Correct hypovolemia prior to administration 1
- Verify no contraindications exist (aspirin/NSAID-induced asthma, active peptic ulcer disease, GI bleeding, cerebrovascular hemorrhage, severe renal impairment) 2, 3
For breakthrough pain:
- Do not increase the dose or frequency of ketorolac 1
- Consider supplementing with low-dose opioids as needed unless contraindicated 1
- Switch to alternative analgesics as soon as clinically appropriate 1
High-Risk Population Adjustments
Elderly patients (≥60 years) require:
- Reduced dosing (15 mg every 6 hours, maximum 40-60 mg daily) 3, 1
- Baseline monitoring: blood pressure, BUN, creatinine, liver function tests, CBC, fecal occult blood 3
- Repeat monitoring every 3 months if extended use is considered (though duration should not exceed 5 days) 3
Avoid concurrent use with:
- Other NSAIDs (including ibuprofen) due to additive toxicity without additional analgesic benefit 4
- Wait 6-8 hours after last ibuprofen dose before administering ketorolac 4
Common Pitfalls to Avoid
- Never exceed 5 days of treatment - this is a hard stop regardless of pain control 2, 1
- Never mix ketorolac in a syringe with morphine, meperidine, promethazine, or hydroxyzine - this causes precipitation 1
- Never increase frequency beyond every 6 hours - consider alternative or adjunctive analgesics instead 1
- Never use in patients with active bleeding or coagulopathy - ketorolac has reversible antiplatelet effects 2, 3